Navigation Links
RoosterBio Launches New cGMP Stem Cell Product Portfolio, Maintaining Unwavering Commitment to Driving the Explosive Regenerative Medicine Industry
Date:9/14/2017

RoosterBio Inc, today, proudly announces the launch of its CliniControl™ (CC) product portfolio, clinically-relevant starting and ancillary materials that generate unprecedented efficiencies in adult stem cell manufacturing, accelerating clinical translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product portfolio will radically simplify major steps in product development and clinical translation, improving the likelihood of commercial success for RoosterBio customers.

The first in the CliniControl line of products, RoosterNourish™-MSC-CC bioprocess medium sets the new standard of industry-leading performance. RoosterNourish-MSC-CC is a first-in-class, standardized, xeno-free (XF) bioprocess medium engineered to support not only 2D (plastic adherent), but also 3D suspension culture of hMSCs in allogeneic and autologous therapeutic manufacturing. Formulated specifically for clinical research process and product developers, RoosterNourish-MSC-CC yields superior media productivity, leading to drastically reduced cost of goods as compared to other hMSC culture media. The highly productive RoosterNourish medium is designed for batch 2D and fed-batch 3D cultures and seamlessly translates between culture platforms enabling scalable hMSC culture, delivering robust, reproducible and standardized results at a commercially-viable cost of goods.

RoosterBio CliniControl bioprocess media are manufactured with methods and controls that conform with current good manufacturing practices (cGMP) for medical devices, 21 CFR Part 820 and will be supported by Quality documentation that significantly reduces customer time spent preparing investigational new drug (IND) submissions. CliniControl products are analogous to RoosterBio’s Development Grade (RUO) products, but adhere to more stringent quality regulations appropriate for their intended use. RoosterBio’s Quality Assurance Team is committed to providing the highest quality products in compliance with applicable regulatory requirements to satisfy customers’ needs and meet or exceed their expectations.

Of the new product portfolio, Director of Business Development and Strategic Marketing, Dr. Priya Baraniak said: “RoosterBio was founded on the mission to accelerate Regenerative Medicine, bringing life saving cures to patients. Our entire team has been proud to see our vision come to fruition over the last three and a half years, with the many process development and R&D successes of our customers. We are so excited to continue on our mission by supporting our customers into clinical translation and commercialization with our unprecedented, off-the-shelf cGMP product portfolio. We are standing at the precipice of a major transformation in the adult stem cell therapy arena, and we are grateful to play a role in this story.”

To learn more about CliniControl products, please contact Dr. Priya Baraniak at priya(at)roosterbio(dot)com.

About RoosterBio, Inc.:
RoosterBio, Inc. is a privately held stem cell tools and technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio and adult stem cells, please visit http://www.roosterbio.com, follow on twitter (@RoosterBio), or read our corporate blog (http://www.roosterbio.blogspot.com).

Read the full story at http://www.prweb.com/releases/2017/09/prweb14694463.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Margot Connor, CEO, RoosterBio Inc., Frederick Innovative Technology Center, Inc expected graduate earns “Top 10” Technology Industry Award
2. RoosterBio Launches a Xeno-Free Bioreactor Feed to Streamline Cell Expansion & Efficiently Reach Billions of hMSCs
3. RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network
4. Engineered by RoosterBio Inc.: Universal Bioprocess Bags to Streamline Closed System Stem Cell Production
5. Designed by RoosterBio Inc.: New Xeno-free Cell Culture Media Product Developed to Accelerate Manufacturing and Commercialization of Adult Stem Cell Products
6. RoosterBio Inc. Launches Industry’s First Ready-to-Print Stem Cell Product
7. Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology
8. Jenway Launches Genova Bio Spectrophotometer for Life Science Applications
9. LabRoots Launches Fall STEM Scholarship for College Students
10. Cynvenio Launches Newest LiquidBiopsy HER2 Expression Test
11. Nanomedical Diagnostics Launches New Agile Biosensor to Accelerate Label-free Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2019)... (PRWEB) , ... September 24, ... ... be presenting their latest research in the area of high-level X-ray methods ... Dr. Pamela Smith, COO of Improved Pharma, will present “Synchrotron X-Ray Diffraction ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... has completed training and site qualification for clinical trial sites and physician investigators. ... screening of potential clinical trial participants. , Clinical trial sites are currently located ...
(Date:9/22/2019)... , ... September 20, 2019 , ... ... of Brain-Derived Neurotrophic Factor (BDNF) testing in serum . BDNF plays a ... BDNF stimulates the growth and differentiation of new neurons in the brain involved ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester ... today that the U.S. Patent and Trademark Office (USPTO) and European Patent Office ... class recommendations for hypertension treatment. , The patent applies to Geneticure’s first ...
Breaking Biology Technology:
(Date:9/24/2019)... ... September 24, 2019 , ... HT Medical ... porous titanium spinal implants with the expansion of its proprietary Ti3D® spinal interbody ... tripling the number of cervical and lumbar instrumentation sets available for surgical use. ...
(Date:9/17/2019)... ... 17, 2019 , ... Last week, Blackrock Microsystems, LLC, Neuro ... Medical University of Warsaw, met at the Presidential Palace of the Republic of ... system as part of an initiative called "Startups in the Palace – Cooperation," ...
(Date:9/11/2019)... ... 2019 , ... Newly released “Dream in Color” by poet ... a beautiful and thought-provoking journey through five chapters of human experience. , The ... and other times, Whittaker wrote to Srinivasan’s paintings. Together, the dynamic watermedia and ...
Breaking Biology News(10 mins):